Skip to content
Home/Companies/Biotech/Apogenix

Apogenix

Biotech·Germany·Active·21yr hold
Entry
2005
Hold
21yr
Status
Active

Who owns Apogenix?

Apogenix is a German Biotech company, currently owned by dievini Hopp BioTech holding since 2005.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
dievini Hopp BioTech holding
Investor
dievini Hopp BioTech holding
dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from dievini Hopp BioTech holding (Evergreen Balance Sheet)

Other portfolio companies in the same fund.

Heidelberg Pharma
Heidelberg Pharma
Active
BiotechGermany· 2009
Novaliq
Novaliq
Active
PharmaGermany· 2007
Immatics
Immatics
Active
BiotechGermany· 2006
CureVac
CureVac
Exited 2025
BiotechGermany· 2005
to BioNTech
Molecular Health
Exited 2026
SaaSGermany· 2004

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Apogenix?

Apogenix is currently owned by dievini Hopp BioTech holding, through dievini Hopp BioTech holding (Evergreen Balance Sheet), since 2005.

When did dievini Hopp BioTech holding acquire Apogenix?

dievini Hopp BioTech holding acquired Apogenix in 2005.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue